N4-(2-(1H-indol-3-yl)ethyl)-6-chloro-N2-(7-methyl-1Hindazol-5-yl)quinazoline-2,4-diamine

ID: ALA4095142

PubChem CID: 137655924

Max Phase: Preclinical

Molecular Formula: C26H22ClN7

Molecular Weight: 467.96

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(Nc2nc(NCCc3c[nH]c4ccccc34)c3cc(Cl)ccc3n2)cc2cn[nH]c12

Standard InChI:  InChI=1S/C26H22ClN7/c1-15-10-19(11-17-14-30-34-24(15)17)31-26-32-23-7-6-18(27)12-21(23)25(33-26)28-9-8-16-13-29-22-5-3-2-4-20(16)22/h2-7,10-14,29H,8-9H2,1H3,(H,30,34)(H2,28,31,32,33)

Standard InChI Key:  KIBIXLNZTYVMJL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
   25.4512   -4.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4501   -5.7804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1581   -6.1894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1563   -4.5520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8649   -4.9573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8657   -5.7763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5742   -6.1834    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2825   -5.7725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2778   -4.9504    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5686   -4.5471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7434   -4.5525    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   27.5643   -3.7299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.9918   -6.1784    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6979   -5.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4044   -6.1773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1100   -5.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6903   -4.9559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8544   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8501   -2.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1402   -2.1030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0484   -1.2938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2481   -1.1282    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3934   -2.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8484   -1.8378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0544   -2.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8043   -2.7823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3542   -3.3865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1462   -3.2132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3930   -4.5429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1069   -4.9484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7132   -4.3947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.3739   -3.6470    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.5581   -3.7387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8192   -6.1727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1 11  1  0
 10 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 30  2  0
 29 17  2  0
 17 14  1  0
 12 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 24  1  0
 23 20  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 33 29  1  0
 16 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4095142

    ---

Associated Targets(Human)

PAK4 Tchem Serine/threonine-protein kinase PAK 4 (3212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.96Molecular Weight (Monoisotopic): 467.1625AlogP: 6.35#Rotatable Bonds: 6
Polar Surface Area: 94.31Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.84CX Basic pKa: 3.90CX LogP: 6.16CX LogD: 6.16
Aromatic Rings: 6Heavy Atoms: 34QED Weighted: 0.23Np Likeness Score: -1.55

References

1. Hao C, Huang W, Li X, Guo J, Chen M, Yan Z, Wang K, Jiang X, Song S, Wang J, Zhao D, Li F, Cheng M..  (2017)  Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy.,  131  [PMID:28284095] [10.1016/j.ejmech.2017.02.063]

Source